Trials / Unknown
UnknownNCT00231712
Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant
Prospective Analysis of the Patterns of Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Autologous/Allogeneic Stem Cell Transplant
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (planned)
- Sponsor
- Julius-Maximilians University · Academic / Other
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to conduct an analysis of the influences of 1. conventional chemotherapy 2. high-dose chemotherapy followed by autologous stem cell transplant 3. high-dose chemotherapy followed by allogeneic stem cell transplant on the recovery of the immune system. Detailed analysis will help to better understand the pathways of recovery of the immune system following chemotherapy as well as the pathways of recovery of the immune system following autologous or allogeneic stem cell transplantation.
Detailed description
Detailed analysis will be performed at preselected time points following therapy by * standard flow cytometry in combination with intracellular cytokine/antigen staining * spectratype analysis * TREC assays
Conditions
Timeline
- Start date
- 2005-03-01
- Completion
- 2009-02-01
- First posted
- 2005-10-04
- Last updated
- 2006-08-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00231712. Inclusion in this directory is not an endorsement.